FDA Approves First CAR-T for Chronic Lymphocytic Leukemia

(MedPage Today) -- The FDA granted accelerated approval to lisocabtagene maraleucel (liso-cel, Breyanzi) for pretreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), drugmaker Bristol Myers Squibb announced on Thursday...
Source: MedPage Today Public Health - Category: American Health Source Type: news